Complement Factor D Deficiency
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Complement Factor D Deficiency
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Complement deficiency disease
|
0.400 |
Biomarker
|
group |
HPO |
|
|
|
Recurrent bacterial infection
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Variable expressivity
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Dermatitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
<b>Abbreviations:</b> atopic dermatitis: AD; interleukin: IL; persistent facial dermatitis: PFD; T-helper cell type 1: Th1; T-helper cell type 2: Th2; T-helper cell type 17: Th17; tumor necrosis factor-∝: TNF-∝.
|
31132923 |
2019 |
Coronary Artery Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
3D: Three-dimensional; 3DR: Three-dimensional Reconstruction; 3D-QCA: Three-dimensional quantitative coronary angiography; ALWSS: Areas of low wall shear stress; CAD: Coronary artery disease; CFD: Computational fluid dynamics; %DS: Diameter stenosis percentage; EPCS: End point of counter-rotating streamlines; FSI: Fluid-structure interaction; IVUS: Intravascular ultrasound; LAD: Left anterior descending; MWSS: Maximum wall shear stress; SST: Shear stress transport; TAWSS: Time-averaged wall shear stress; WSS: wall shear stress; WPG: Wall pressure gradient; MWPG: Maximum wall pressure gradient; FFR: Fractional flow reserve; iFR: Instantaneous wave-free ratio.
|
27467730 |
2017 |
Colorectal Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
CFD was more accurate than CEA or CA19-9 in diagnosing CRC.
|
22975639 |
2013 |
Coughing
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
CFD transient simulation of the cough clearance process using an Eulerian wall film model.
|
27380322 |
2017 |
Interrupted aortic arch
|
0.010 |
Biomarker
|
disease |
BEFREE |
CFD analysis in IAA can provide a clinical reference, and the results should be further studied in depth in the future.
|
31197221 |
2019 |
Tuberculosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
CFD simulations for paper-based DNA amplification reaction (LAMP) of Mycobacterium tuberculosis-point-of-care diagnostic perspective.
|
31845080 |
2020 |
Anastomosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
A CFD study was carried out to clarify the reasons for the stagnation and to find favorable anastomosis methods from a fluid dynamical point of view.
|
31610882 |
2020 |
Fusiform Aneurysm
|
0.010 |
Biomarker
|
disease |
BEFREE |
A comparative CFD analysis of common carotid fusiform aneurysm in canine models and vertebrobasilar fusiform aneurysm in human patients.
|
28945061 |
2018 |
Antibody Deficiency Syndrome
|
0.300 |
Biomarker
|
disease |
CTD_human |
A family with complement factor D deficiency.
|
11457876 |
2001 |
Immunologic Deficiency Syndromes
|
0.300 |
Biomarker
|
group |
CTD_human |
A family with complement factor D deficiency.
|
11457876 |
2001 |
Neisseriaceae Infections
|
0.300 |
Biomarker
|
group |
CTD_human |
A family with complement factor D deficiency.
|
11457876 |
2001 |
Papillary thyroid carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
A total of 21 central node genes were identified as key genes in the PTC disease process including complement factor D (CFD), Collagen Type I α 1 Chain (COL1A1), Extracellular Matrix Protein 1 (ECM1) and Fibronectin 1 (FN1).
|
30344727 |
2018 |
Blood spots
|
0.010 |
Biomarker
|
disease |
BEFREE |
A total of 2264 singletons and 1144 twins from Upstate KIDS (born 2008-2010) had adiponectin, leptin, resistin and complement factor D measured in newborn blood spots.
|
29781193 |
2018 |
Complement Factor D Deficiency
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A type III complement factor D deficiency: Structural insights for inhibition of the alternative pathway.
|
29522842 |
2018 |
Complement deficiency disease
|
0.400 |
Biomarker
|
group |
GENOMICS_ENGLAND |
A type III complement factor D deficiency: Structural insights for inhibition of the alternative pathway.
|
29522842 |
2018 |
Neisseria infection
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
A young man suffering from recurrent Neisseria infections was shown to lack detectable serum complement factor D hemolytic activity.
|
2687330 |
1989 |
Asbestosis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Adipokine adipsin is associated with the degree of lung fibrosis in asbestos-exposed workers.
|
22832039 |
2012 |
Pulmonary Fibrosis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Adipokine adipsin is associated with the degree of lung fibrosis in asbestos-exposed workers.
|
22832039 |
2012 |
Pulmonary Fibrosis - from Asbestos Exposure
|
0.300 |
Biomarker
|
disease |
CTD_human |
Adipokine adipsin is associated with the degree of lung fibrosis in asbestos-exposed workers.
|
22832039 |
2012 |
Alveolitis, Fibrosing
|
0.300 |
Biomarker
|
disease |
CTD_human |
Adipokine adipsin is associated with the degree of lung fibrosis in asbestos-exposed workers.
|
22832039 |
2012 |